Biotechnology Companies By Bonds Weight

Bond Positions Weight
Bond Positions WeightEfficiencyMarket RiskExp Return
1ENGN enGene Holdings Common
97.03
 0.03 
 11.33 
 0.30 
2ALT Altimmune
15.26
 0.02 
 5.84 
 0.12 
3MBIO Mustang Bio
0.0
(0.17)
 8.11 
(1.41)
4MBRX Moleculin Biotech
0.0
(0.09)
 6.34 
(0.60)
5MCRB Seres Therapeutics
0.0
 0.04 
 6.67 
 0.27 
6MDCX Medicus Pharma Ltd
0.0
(0.06)
 9.51 
(0.56)
7MDGL Madrigal Pharmaceuticals
0.0
 0.02 
 3.52 
 0.08 
8EQ Equillium
0.0
(0.03)
 4.55 
(0.16)
9ME 23Andme Holding Co
0.0
(0.08)
 6.15 
(0.49)
10MDXG MiMedx Group
0.0
 0.12 
 3.55 
 0.42 
11MDXH MDxHealth SA ADR
0.0
(0.01)
 3.66 
(0.04)
12MEIP MEI Pharma
0.0
(0.05)
 2.10 
(0.09)
13032095AH4 AMPHENOL P NEW
0.0
(0.05)
 0.52 
(0.02)
14MESO Mesoblast
0.0
 0.23 
 7.67 
 1.77 
15032095AK7 US032095AK70
0.0
(0.13)
 0.55 
(0.07)
16DMAC DiaMedica Therapeutics
0.0
 0.10 
 5.91 
 0.59 
17032095AJ0 US032095AJ08
0.0
(0.15)
 0.49 
(0.07)
18MGNX MacroGenics
0.0
(0.08)
 3.61 
(0.28)
19VALN Valneva SE ADR
0.0
 0.02 
 4.20 
 0.06 
20VANI Vivani Medical
0.0
(0.02)
 2.94 
(0.05)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Percentage of fund asset invested in fixed income securities. About 30% of U.S. mutual funds invest in bonds.Funds that have over 60% of asset value invested in bonds or or other fixed income securities would usually attract conservative investors.